Analysen von Richard Vosser
| 01.10.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.09.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.09.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 17.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 15.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.09.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 10.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 10.09.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 09.09.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 30.08.21 | Bayer Overweight | JP Morgan Chase & Co. | |
| 06.08.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.08.21 | Bayer Overweight | JP Morgan Chase & Co. | |
| 05.08.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.08.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 02.08.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.07.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 29.07.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.07.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 27.07.21 | Bayer Overweight | JP Morgan Chase & Co. | |
| 26.07.21 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 23.07.21 | Merck Overweight | JP Morgan Chase & Co. | |
| 21.07.21 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 16.07.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 16.07.21 | Bayer Overweight | JP Morgan Chase & Co. | |
| 07.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.07.21 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 05.07.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.07.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 01.07.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 29.06.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 28.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 24.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 10.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.06.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.05.21 | Bayer overweight | JP Morgan Chase & Co. | |
| 21.05.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 21.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 21.05.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.05.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 20.05.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 20.05.21 | Roche Neutral | JP Morgan Chase & Co. | |